Evaluation of animal models for intestinal first-pass metabolism of drug candidates to be metabolized by CYP3A enzymes via in vivo and in vitro oxidation of midazolam and triazolam

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  2013-06-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/00498254.2012.751517PMID 23282066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice.

  2011cited by this paper
• Influence of dietary substances on intestinal drug metabolism and transport.

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice

  2009cited by this paper
• The biological and clinical role of drug transporters at the intestinal barrier.

  2009cited by this paper
• Tissue-specific mRNA expression profiles of human solute carrier 35 transporters.

  2009cited by this paper
• Impact of time-dependent inactivation on the estimation of enzyme kinetic parameters for midazolam.

  2009cited by this paper
• Comparative gene expression of intestinal metabolizing enzymes

  2009cited by this paper
• Inhibition and Stimulation of Intestinal and Hepatic CYP3A Activity: Studies in Humanized CYP3A4 Transgenic Mice Using Triazolam

  2009cited by this paper
• Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies.

  2008cited by this paper
• Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

  2008influential reference
• Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.

  2008cited by this paper
• Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes.

  2008cited by this paper
• Naringin is a Major and Selective Clinical Inhibitor of Organic Anion‐Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice

  2007cited by this paper
• Intestinal and Hepatic Metabolic Activity of Five Cytochrome P450 Enzymes: Impact on Prediction of First-Pass Metabolism

  2006influential reference
• MDR- and CYP3A4-Mediated Drug–Drug Interactions

  2006cited by this paper
• A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.

  2006influential reference
• Structures of cytochrome P450 3A4.

  2005cited by this paper
• Role of CYP3A enzymes in the biotransformation of triazolam in rat liver

  2004cited by this paper
• Isolation and Characterization of a New Major Intestinal CYP3A Form, CYP3A62, in the Rat

  2004cited by this paper
• The small intestine as a xenobiotic-metabolizing organ.

  2003cited by this paper
• Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

  2003cited by this paper
• Importance of P‐glycoprotein for drug disposition in humans

  2003cited by this paper
• In Vitro, Pharmacokinetic, and Pharmacodynamic Interactions of Ketoconazole and Midazolam in the Rat

  2002cited by this paper
• Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation.

  2002cited by this paper
• Sex‐related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P‐glycoprotein

  2002influential reference
• A Kinetic Model for the Metabolic Interaction of Two Substrates at the Active Site of Cytochrome P450 3A4*

  2001cited by this paper
• Covalent alteration of the CYP3A4 active site: evidence for multiple substrate binding domains.

  2001cited by this paper
• Active secretion and enterocytic drug metabolism barriers to drug absorption.

  2001cited by this paper
• Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity.

  2000influential reference
• Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.

  2000cited by this paper
• Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.

  1997influential reference
• Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.

  1996cited by this paper
• Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

  1989cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Drug Transporter - Enzyme Crossroads: Does OATP2B1 Shape Cyp3a-Driven Midazolam Metabolism in Rats?

  2025cites this paper
• Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism

  2022cites this paper
• Different modulation of Panax notoginseng on the absorption profiling of triptolide and tripterine from Tripterygium wilfordii in rat intestine

  2018cites this paper
• Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat

  2018cites this paper
• A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice

  2018cites this paper
• Développement et utilisation de modèles in vitro et de données précliniques pour augmenter la prédictibilité de la perméabilité et du métabolisme intestinal chez l'humain

  2016cites this paper
• Species Similarities and Differences in Pharmacokinetics and Distribution of Antiretroviral Drugs

  2014cites this paper
• 1-Aminobenzotriazole Modulates Oral Drug Pharmacokinetics through Cytochrome P450 Inhibition and Delay of Gastric Emptying in Rats

  2014cites this paper